Skip to main content
. 2019 Oct 22;19:977. doi: 10.1186/s12885-019-6220-1

Fig. 2.

Fig. 2

a Median (95% CI) pre-RT baseline TLCs (X 103/µl), b Slope of median (95% CI) TLCs reduction over time (X 103/µl per day), c Median (95% CI) lowest TLCs (X 103/µl), and d Median (95% CI) time to lowest TLCs (days) in patients treated with CFRT/CMT, SBRT/CMT, and SBRT/NFV